:Effects of Pharmaceutical Care in Stroke Patients

NACompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2023

Conditions
Stroke
Interventions
BEHAVIORAL

Clinical Pharmacist Led Pharmaceutical Care

Within the scope of pharmaceutical care, medication review services for past and current medication use were provided by the clinical pharmacist. The patients in the intervention group were given verbal information about the definition of stroke, symptoms, how to manage risk factors, and their medications by the clinical pharmacist on the day of discharge, in addition to the neurologist. Each patient in the intervention group had a scheduled meeting with the clinical pharmacist. During the 1-year follow-up the patient education given by the clinical pharmacist was repeated every 3 months.

Trial Locations (1)

Unknown

Marmara University Pendik Research and Training Hospital, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Marmara University

OTHER